Equity Analysis

Quarterly Results

    Dr Reddys Laboratories Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    500124
    INE089A01031
    322.4783105
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    DRREDDY
    23.29
    112015.49
    EPS(TTM)
    Face Value()
    Div & Yield %:
    57.64
    1
    0.6
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales6678.805823.905081.80
Other Operating Income17.5017.3023.00
Other Income 207.60217.80212.70
Total Income6903.906059.005317.50
Total Expenditure 3974.703888.203726.20
PBIDT2929.202170.801591.30
Interest 28.407.105.90
PBDT2900.802163.701585.40
Depreciation260.00249.80246.20
Tax703.30466.60270.20
Fringe Benefit Tax0.000.000.00
Deferred Tax55.4030.1034.20
Reported Profit After Tax1882.101417.201034.80
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item1882.101417.201034.80
EPS (Unit Curr.)113.0085.1062.14
EPS (Adj) (Unit Curr.)22.6017.0212.43
Calculated EPS (Unit Curr.)112.8484.9662.04
Calculated EPS (Adj) (Unit Curr.)22.5716.9912.41
Calculated EPS (Ann.) (Unit Curr.)451.34339.86248.15
Calculated EPS (Adj) (Ann.) (Unit Curr.)90.2767.9749.63
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity83.4083.4083.40
Reserve & Surplus0.000.000.00
Face Value5.005.005.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)43.8637.2731.31
PBDTM(%)43.4337.1531.20
PATM(%)28.1824.3320.36
Dividend Per Share(Rs)0.000.000.00
Diluted EPS112.8084.9762.04